Your browser version may not work well with NCBI's Web applications. More information here...
1: Emerg Infect Dis. 2004 Dec;10(12):2218-20.Click here to read Links

Protective effectiveness of hantavirus vaccine.

Park K, Kim CS, Moon KT.

National Cancer Center, Goyang, Republic of Korea. bachism@empal.com

A case-control study in the Republic of Korea evaluated the protective effectiveness of the hantavirus vaccine. Point estimates showed increasing effectiveness with increasing numbers of doses received: 25% for one dose, 46% for two doses, and 75% for three doses. All 95% confidence intervals overlapped zero; therefore, the findings could be due to chance.

PMID: 15663866 [PubMed - indexed for MEDLINE]